Correction to: Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries.
作者信息
Fontrier Anna-Maria, Visintin Erica, Kanavos Panos
机构信息
Department of Health Policy, LSE Health-Medical Technology Research Group (MTRG), Cowdray House, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK.
出版信息
Pharmacoecon Open. 2022 Jul;6(4):629. doi: 10.1007/s41669-022-00345-3.
Abstract
摘要
相似文献
1
Correction to: Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries.对《卫生技术评估系统的异同及其对覆盖决策的影响：来自32个国家的证据》的更正
Pharmacoecon Open. 2022 Jul;6(4):629. doi: 10.1007/s41669-022-00345-3.
2
Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries.卫生技术评估系统的异同及其对覆盖决策的影响：来自32个国家的证据
Pharmacoecon Open. 2022 May;6(3):315-328. doi: 10.1007/s41669-021-00311-5. Epub 2021 Nov 29.
3
Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries.为何针对相同药物的卫生技术评估覆盖建议在不同地区存在差异？应用混合方法框架对四个欧洲国家的罕见病药物决策进行系统比较。
Eur J Health Econ. 2017 Jul;18(6):715-730. doi: 10.1007/s10198-016-0823-0. Epub 2016 Aug 18.
4
Transparency vs. closed-door policy: do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis.透明度与闭门政策：流程特征对报道决策结果是否有影响？一项统计分析。
Health Policy. 2013 Oct;112(3):187-96. doi: 10.1016/j.healthpol.2013.04.011. Epub 2013 May 10.
5
The review process used by US health care plans to evaluate new medical technology for coverage.美国医疗保健计划用于评估新医疗技术是否纳入保险范围的审查过程。
J Gen Intern Med. 1996 May;11(5):294-302. doi: 10.1007/BF02598272.
6
EXPANDING EVIDENCE-BASED TECHNOLOGY ASSESSMENT FOR COVERAGE IN WASHINGTON STATE.拓展基于证据的技术评估以用于华盛顿州的医保覆盖范围。
Int J Technol Assess Health Care. 2016 Jan;32(3):140-6. doi: 10.1017/S0266462316000192. Epub 2016 Aug 5.
7
The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries.健康技术评估在选定中等收入国家药品报销中的作用。
Health Policy. 2010 May;95(2-3):174-84. doi: 10.1016/j.healthpol.2009.12.008. Epub 2010 Jan 13.
8
The role of health technology assessment in coverage decisions on newborn screening.健康技术评估在新生儿筛查覆盖决策中的作用。
Int J Technol Assess Health Care. 2011 Oct;27(4):313-21. doi: 10.1017/S0266462311000468.
9
Technology assessment: relationship to coverage issues--a case for temporary coverage decisions.
Am J Kidney Dis. 1999 Jan;33(1):208-10. doi: 10.1016/s0272-6386(99)70286-6.
10
A comparative analysis of coverage decisions for outpatient pharmaceuticals: evidence from Denmark, Norway and Sweden.门诊药品覆盖决策的比较分析：来自丹麦、挪威和瑞典的证据
Health Policy. 2015 Feb;119(2):203-11. doi: 10.1016/j.healthpol.2014.12.013. Epub 2014 Dec 22.
引用本文的文献
1
Institutionalization of Health Technology Assessment of medical devices: a cluster analysis of EU, EEA, and EFTA countries.医疗器械卫生技术评估的制度化：对欧盟、欧洲经济区和欧洲自由贸易联盟国家的聚类分析
Int J Technol Assess Health Care. 2025 Jul 8;41(1):e44. doi: 10.1017/S0266462325100251.
Zotero 插件